BioSpace News Archive

Drug Development

VBL Therapeutics Release: Phase I/II Data of VB-111 Demonstrate Anti-Tumor Effects With Increase in Overall Survival With This Anti-Angiogenic Gene Therapy, in Patients With Recurrent Glioblastoma Multiforme

June 3, 2013
·
1 min read
Drug Development

AstraZeneca PLC Advances PARP Inhibitor Into Phase 3 Trial With BRACAnalysis®

June 3, 2013
·
1 min read
Teva Pharmaceutical Industries Limited’s Lonquex®(XM22 lipegfilgrastim) Recommended for Approval in the EU for the Reduction of Chemotherapy-Induced Neutropenia (CIN)

June 3, 2013
·
1 min read
Pharm Country

Royalty Pharma Responds to Elan Corporation PLC’s Tysabri Valuation

June 3, 2013
·
11 min read
BioMidwest

Myriad Genetics, Inc. to Present at the Goldman, Sachs & Co. Global Healthcare Conference

June 3, 2013
·
1 min read
Biotech Bay

VIVUS, Inc. Announces Scientific Presentations

June 3, 2013
·
1 min read
Business

Chimerix, Inc. and Biomedical Advanced Research and Development Authority (BARDA) Continue Collaboration on Development of CMX001 as a Medical Countermeasure Against Smallpox

June 3, 2013
·
1 min read
Biotech Beach

Agendia BV Release: Ground-breaking Research Identifies Molecular Subtyping as a Key to Determining Prognosis and Benefit of Chemotherapy for Breast and Colorectal Cancers

June 3, 2013
·
2 min read
Deals

Elan Corporation PLC Issues Response Document Further Detailing Inadequacy of Royalty Pharma’s Revised Offer

June 3, 2013
·
1 min read
Biotech Beach

Isis Pharmaceuticals, Inc. Announces Exercise of Underwriters’ Option to Purchase Additional Shares

June 3, 2013
·
4 min read